Catalyst Wire Dossier Catalyst Wire Dossier

89Zr-cRGDY ultrasmall silica particle tracer

Zr-89-labeled cRGDY ultrasmall silica particle tracer · Memorial Sloan Kettering Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-cRGDY ultrasmall silica particle tracer, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors [Phase 1]

See pricing